UK Markets close in 22 mins

Ultimovacs ASA (ULTI.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
69.30-0.50 (-0.72%)
At close: 09:41AM CEST
Currency in NOK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.31
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3170.20
52-week low 360.50
50-day moving average 370.35
200-day moving average 388.26

Share statistics

Avg vol (3-month) 325.41k
Avg vol (10-day) 321.46k
Shares outstanding 534.22M
Implied shares outstanding 6N/A
Float 819.09M
% held by insiders 148.02%
% held by institutions 127.83%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-18.77%
Return on equity (ttm)-33.11%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -163.63M
Net income avi to common (ttm)-167.52M
Diluted EPS (ttm)-4.32
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)523.71M
Total cash per share (mrq)15.3
Total debt (mrq)1.74M
Total debt/equity (mrq)0.31
Current ratio (mrq)15.59
Book value per share (mrq)11.93

Cash flow statement

Operating cash flow (ttm)-141.53M
Levered free cash flow (ttm)-81.52M